Evoke Wealth’s Axonics, Inc. Common Stock AXNX Stock Holding History

Evoke Wealth’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-234	Closed	-$5.95K	–	1208
2020 Q1	$5.95K	Buy	+234	New	+$6.96K	﹤0.01%	579

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Evoke Wealth's AXNX Position: Q2 2020 in Review

Evoke Wealth sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2020, closing a stake of 234 shares — an estimated $5.95K sold.

Evoke Wealth first reported a position in AXNX in Q1 2020 and held it in 1 quarter. The position peaked at $5.95K in Q1 2020. 134 funds tracked by Wall St. Rank hold AXNX as of Q2 2020.

Evoke Wealth reported no remaining Axonics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Evoke Wealth sold 234 Axonics, Inc. Common Stock shares in Q2 2020, an estimated $5.95K.
Evoke Wealth first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
Evoke Wealth's Axonics, Inc. Common Stock position peaked at $5.95K in Q1 2020.
134 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2020.

Based on Evoke Wealth's 13F filing for Q2 2020, filed 10 Aug 2020.